These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26139297)

  • 21. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.
    Tada N; Virmani R; Grant G; Bartlett L; Black A; Clavijo C; Christians U; Betts R; Savage D; Su SH; Shulze J; Kar S
    Circ Cardiovasc Interv; 2010 Apr; 3(2):174-83. PubMed ID: 20407114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
    Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J
    Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational Bench Testing to Evaluate the Short-Term Mechanical Performance of a Polymeric Stent.
    Bobel AC; Petisco S; Sarasua JR; Wang W; McHugh PE
    Cardiovasc Eng Technol; 2015 Dec; 6(4):519-32. PubMed ID: 26577483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets.
    Busch R; Strohbach A; Rethfeldt S; Walz S; Busch M; Petersen S; Felix S; Sternberg K
    Acta Biomater; 2014 Feb; 10(2):688-700. PubMed ID: 24148751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in coronary stent technology--active drug-loaded stent surfaces for prevention of restenosis and improvement of biocompatibility.
    Sternberg K; Grabow N; Petersen S; Weitschies W; Harder C; Ince H; Kroemer HK; Schmitz KP
    Curr Pharm Biotechnol; 2013; 14(1):76-90. PubMed ID: 23092260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating.
    Jabara R; Chronos N; Conway D; Molema W; Robinson K
    JACC Cardiovasc Interv; 2008 Feb; 1(1):81-7. PubMed ID: 19393150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing.
    Pendyala L; Jabara R; Robinson K; Chronos N
    J Interv Cardiol; 2009 Feb; 22(1):37-48. PubMed ID: 19281521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower Thrombogenicity.
    Rudolph A; Teske M; Illner S; Kiefel V; Sternberg K; Grabow N; Wree A; Hovakimyan M
    PLoS One; 2015; 10(12):e0142075. PubMed ID: 26641662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Ultimaster® coronary stent system: state of the art.
    Longo G; La Manna A; Capodanno D; Tamburino C
    Minerva Cardioangiol; 2015 Jun; 63(3):193-203. PubMed ID: 25900560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.
    Palmerini T; Benedetto U; Biondi-Zoccai G; Della Riva D; Bacchi-Reggiani L; Smits PC; Vlachojannis GJ; Jensen LO; Christiansen EH; Berencsi K; Valgimigli M; Orlandi C; Petrou M; Rapezzi C; Stone GW
    J Am Coll Cardiol; 2015 Jun; 65(23):2496-507. PubMed ID: 26065988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials.
    de Waha A; Stefanini GG; King LA; Byrne RA; Serruys PW; Kufner S; Meier B; Jüni P; Kastrati A; Windecker S
    Int J Cardiol; 2013 Oct; 168(6):5162-6. PubMed ID: 23993323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design.
    Räber L; Kelbaek H; Ostoijc M; Baumbach A; Tüller D; von Birgelen C; Roffi M; Pedrazzini G; Kornowski R; Weber K; Heg D; Matter C; Lüscher T; Taniwaki M; Meier B; Jüni P; Windecker S
    EuroIntervention; 2012 Apr; 7(12):1435-43. PubMed ID: 22301368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
    Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design.
    Jeger R; Pfisterer M; Alber H; Eberli F; Galatius S; Naber C; Pedrazzini G; Rickli H; Jensen JS; Vuilliomenet A; Gilgen N; Kaiser C
    Am Heart J; 2012 Feb; 163(2):136-41.e1. PubMed ID: 22305828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The SYNERGY biodegradable polymer everolimus eluting coronary stent: Porcine vascular compatibility and polymer safety study.
    Wilson GJ; Marks A; Berg KJ; Eppihimer M; Sushkova N; Hawley SP; Robertson KA; Knapp D; Pennington DE; Chen YL; Foss A; Huibregtse B; Dawkins KD
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):E247-57. PubMed ID: 26009986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary drug-eluting stents: from design optimization to newer strategies.
    Sun D; Zheng Y; Yin T; Tang C; Yu Q; Wang G
    J Biomed Mater Res A; 2014 May; 102(5):1625-40. PubMed ID: 23703913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
    Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE; Martinez EE;
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):665-73. PubMed ID: 19670303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials.
    Stefanini GG; Byrne RA; Serruys PW; de Waha A; Meier B; Massberg S; Jüni P; Schömig A; Windecker S; Kastrati A
    Eur Heart J; 2012 May; 33(10):1214-22. PubMed ID: 22447805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term coronary arterial response to biodegradable polymer biolimus-eluting stents in comparison with durable polymer sirolimus-eluting stents and bare-metal stents: five-year follow-up optical coherence tomography study.
    Kuramitsu S; Sonoda S; Yokoi H; Iwabuchi M; Nishizaki Y; Shinozaki T; Domei T; Hyodo M; Inoue K; Shirai S; Ando K; Nobuyoshi M
    Atherosclerosis; 2014 Nov; 237(1):23-9. PubMed ID: 25190308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.